Ganesh V. Kaundinya

2014

In 2014, Ganesh V. Kaundinya earned a total compensation of $1.4M as Chief Scientific Officer and Senior Vice President, Research at Momenta Pharmaceuticals, a 51% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$163,468
Option Awards$429,440
Salary$400,656
Stock Awards$346,844
Other$12,852
Total$1,353,260

Kaundinya received $429.4K in option awards, accounting for 32% of the total pay in 2014.

Kaundinya also received $163.5K in non-equity incentive plan, $400.7K in salary, $346.8K in stock awards and $12.9K in other compensation.

Rankings

In 2014, Ganesh V. Kaundinya's compensation ranked 6,243rd out of 13,032 executives tracked by ExecPay. In other words, Kaundinya earned more than 52.1% of executives.

ClassificationRankingPercentile
All
6,243
out of 13,032
52nd
Division
Manufacturing
2,272
out of 4,965
54th
Major group
Chemicals And Allied Products
759
out of 1,690
55th
Industry group
Drugs
592
out of 1,369
57th
Industry
Biological Products, Except Diagnostic Substances
114
out of 241
53rd
Source: SEC filing on April 27, 2017.

Kaundinya's colleagues

We found four more compensation records of executives who worked with Ganesh V. Kaundinya at Momenta Pharmaceuticals in 2014.

2014

Craig Wheeler

Momenta Pharmaceuticals

Chief Executive Officer

2014

James Roach

Momenta Pharmaceuticals

Chief Medical Officer

2014

Bruce Leicher

Momenta Pharmaceuticals

General Counsel

2014

Richard Shea

Momenta Pharmaceuticals

Chief Financial Officer

You may also like